semaglutide and tirzepatide side effects Switching to Tirzepatide: A Provider's Guide does tirzepatide have the same
Description
Glucagon-like peptide-1 (GLP-1) receptor agonists were touted as breakthrough drugsin 2023 and their popularity has soared since. More than 4 million items of tirzepatide and semaglutide were dispensed on the NHS in England in 2025/20261, while around2.5 million people each monthaccessed GLP-1s privately at the end of 2025, according to James Kingsland, chair of []

Or maybe you're treating someone with binge eating disorder and

Originally developed for diabetes, these drugs are now popular for weight loss, especially following expanded approval for adolescents.

Find out who may be eligible, who should avoid it, its current UK regulatory status, potential side effects, and how to speak to your GP about obesity treatment options.

Obesity is a chronic disease
